Icon boosts bioanalytical presence through Prevalere buy
![Icon boosts bioanalytical presence through Prevalere buy](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_small/2/5/9/2/262952-4-eng-GB/Icon-boosts-bioanalytical-presence-through-Prevalere-buy.gif)
Icon's recent $43.2m acquisition of New York-based Prevalere Life Sciences is the latest part of the firm's expansion in the US CRO market.
Outsourcing-Pharma spoke with Icon's VP of bioanalytical development, Brian O'Dwyer, and Prevalere CEO Mario Rocci from a busy AAPS conference in Atlanta.